| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.056 | 0.4 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |